Inaugural Huntington Disease Clinical Research Symposium Organized by the Huntington Study Group

Autor: E. Fine, T. Cahill, Elise Kayson, M. W. Jacobson, S. Kathuria, S. Leit, J. Smith, C. Tang, J. H. Cha, C. Higginson, Melinda M. Swenson, A. J. Lechich, L. Wasserman, H. Patzke, A. Clarke, S. Gevorkian, Noelle E. Carlozzi, Steven M. Hersch, Peter Como, C. Beck, A.E. Kane, S. Sandler, Robert Pacifici, M. C. Chirieac, T. Gillis, Thomas D. Bird, S. Peng, E. A. de Blieck, S. A. Johnson, A. Tomusk, H. D. Rosas, E. Kayson, R. Chesworth, Dennis J. Zgaljardic, J. Lee, S. Hastings, Danielle A. Simmons, David Eidelberg, Hans J. Johnson, V. Magnotta, Bernhard Landwehrmeyer, J. Wang, Elizabeth Aylward, J. L. Goldstein, Vicki L. Wheelock, N. Ramza, J. L. Marsh, S. Montas, Nonna Stepanov, Christopher A. Ross, P. Beaulieu, Elizabeth McCusker, M. K. Ahlijanian, E. Chiu, R. Deziel, Richard H. Myers, L. Carr, B. Walker, Jess G. Fiedorowicz, G. Chadwick, C. McCallum, B. Di Toro, Shannon A. Johnson, J. Srinidhi Mysore, Sharon L. Sims, Josef Priller, F. P. Albayya, Ira Shoulson, Ronald Pierson, J. F. Gusella, Jan Bausch, Kimberly A. Quaid, L. Veatch Goodman, B. Westphal, Henry L. Paulson, L. Deuel, K. Illes, Vijay Dhawan, G. Shapiro, A. Goh, G. M. Peavy, P. Young, M. Adams, J. Latourelle, Ryan Y. Kim, Aimee Aubeeluck, K. Whitlock, Douglas R. Langbehn, J.S. Paulsen, K. M. Biglan, Hillary Lipe, Kevin Duff, William Adams, J. Klager, J. Pallos, J. Dawson, F. L. Huet, D. Johnson, S. Queller, M. Casale, C. Zuccato, G. Suter, Emily Oster, P. Kingsley, S. Lifer, E. Fossale, Mark W. Jacobson, Katharine Moser, E. R. Dorsey, F. Raeppel, D. L. McArthur, A. Pae, Joan M. Harrison, Guerry M. Peavy, A. Lownie, K. Sigvardt, E. Cattaneo, Z. Li, D. Ecker, Russell Katz, A. Duckett, Aileen Shinaman, J. Besterman, Laura Mickes, Andrew Feigin, B. L. Apostol, Jana M. Hanson, Leigh J. Beglinger, L. Michels Thompson, M. Fournel, C. Moskowitz, Mark Guttman, Teresa Tempkin, Peg Nopoulos, H. Sainte-Croix, L. Beglinger, K.B. Whitlock, David Oakes, S. J. Nolan, T. Massood, N. Carlozzi, Jody Corey-Bloom, P. Mattis, G. Rahil, O. Yastrubetskaya, Marcy E. MacDonald, D.R. Langbehn, Heather Buchanan, Jody Goldstein, S. Perlman, Julie C. Stout, R. Stewart, J. Preston, Stephanie Lessig, A. Barbier, Kevin M. Biglan, Wayne R. Matson, G. Schwartz, Yilong Ma, Jane S. Paulsen

Publikováno v: Neurotherapeutics. 5:362-375

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad4ff0e7de53fe6fe4325be2490e29f
https://doi.org/10.1016/j.nurt.2007.10.053

Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process

Autor: D M, Cooper, C M, Bier-Laning, M K, Halford, M K, Ahlijanian, N R, Zahniser

Publikováno v: Molecular pharmacology. 29(2)

This report demonstrates that the D-2 dopamine receptors that are present in rat striatum can directly inhibit the activity of adenylate cyclase in a GTP-dependent manner. N-n-propylnorapomorphine evoked a more pronounced inhibition than did dopamine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c64040627c18f6fc66a3838911f516df
https://pubmed.ncbi.nlm.nih.gov/3005824

Effects of caffeine and 8-phenyltheophylline on the actions of purines and opiates in the guinea-pig ileum

Autor: M K, Ahlijanian, A E, Takemori

Publikováno v: The Journal of pharmacology and experimental therapeutics. 236(1)

The antagonist effects of 8-phenyltheophylline (8-PT) and caffeine against the actions of adenosine, (-)-N6-(R-phenyl-isopropyl)-adenosine (PIA), morphine and nalorphine on the guinea pig ileum preparation were examined. Antagonism of both adenosine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e25a825eaec411cbd1c13f2422e6b127
https://pubmed.ncbi.nlm.nih.gov/3001283

Changes in adenosine receptor sensitivity in morphine-tolerant and -dependent mice

Autor: M K, Ahlijanian, A E, Takemori

Publikováno v: The Journal of pharmacology and experimental therapeutics. 236(3)

Treatment of mice with either a 75-mg morphine pellet (72 h) s.c. or 100 mg/kg of morphine s.c. (3.5 h) did not alter the ED50 of (-)-N6-(phenylisopropyl)adenosine (PIA) in the tail-flick assay. Under the same treatment conditions, caffeine became a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::af2026b7c1b369ef7812245fc68a96e9
https://pubmed.ncbi.nlm.nih.gov/3005548